584 related articles for article (PubMed ID: 10992876)
1. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
Brion JP
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
[TBL] [Abstract][Full Text] [Related]
2. The role of neurofibrillary tangles in Alzheimer disease.
Brion JP
Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
[TBL] [Abstract][Full Text] [Related]
3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
4. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
5. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
[TBL] [Abstract][Full Text] [Related]
6. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
[TBL] [Abstract][Full Text] [Related]
7. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
9. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease. A new take on tau.
Marx J
Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
[No Abstract] [Full Text] [Related]
11. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of Alzheimer's disease].
Alegre M; Noé E; Luquin MR
Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
14. [Tau, amyloid and Alzheimer's disease].
Olesen OF
Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
[TBL] [Abstract][Full Text] [Related]
15. Truncated tau protein as a new marker for Alzheimer's disease.
Novák M
Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
[TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
17. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
19. Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies.
Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2005 Jan; 109(1):25-31. PubMed ID: 15645264
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal abnormalities in Alzheimer's disease.
Lovestone S; Anderton B
Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):883-8. PubMed ID: 1467582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]